{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0224","parameter":[{"name":"assessentDate","valueDate":"2007-02-20"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0224","name":[{"text":"Dose 1 to dose 3 interval of Comvax is 16 weeks.   Series complete for Hep B. \nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete."}],"gender":"female","birthDate":"2006-08-08"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2006-10-31T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2006-12-22T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2007-02-20T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}